Status:
COMPLETED
Indoor Artificial Light at Night and the Relapse Risk of Schizophrenia
Lead Sponsor:
Weizhuo Yi
Conditions:
Schizophrenia Relapse
Light Pollution
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
A randomized crossover trial of ALAN intervention was conducted in patients with chronic schizophrenia in Anhui Mental Health Center from August 15 to September 30, 2022. All participants met the diag...
Eligibility Criteria
Inclusion
- Clinical diagnosis of schizophrenia
- Regularly taking antipsychotics
Exclusion
- Infectious diseases
- Gastrointestinal diseases
- Using antibiotics
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05986409
Start Date
August 1 2022
End Date
September 30 2022
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weizhuo Yi
Hefei, Anhui, China, 230031